| # | Drug | Count |
|---|---|---|
| 0 | MACITENTAN | 42 |
| 1 | LANSOPRAZOLE | 37 |
| 2 | FLUOXETINE HYDROCHLORIDE | 36 |
| 3 | HYDROCHLOROTHIAZIDE | 36 |
| 4 | LORAZEPAM | 36 |
| 5 | MIRTAZAPINE | 36 |
| 6 | TREPROSTINIL | 35 |
| 7 | CANDESARTAN | 33 |
| 8 | TADALAFIL | 33 |
| 9 | ADRENALINUM | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VASOPRESSIN | 30 | 0.0068 |
| 1 | NITRIC OXIDE | 30 | 0.0065 |
| 2 | SODIUM CITRATE | 5 | 0.0040 |
| 3 | OXYTOCIN | 8 | 0.0026 |
| 4 | EPINEPHRINE HYDROCHLORIDE | 1 | 0.0021 |
| 5 | NOREPINEPHRINE BITARTRATE | 30 | 0.0020 |
| 6 | AFICAMTEN | 1 | 0.0020 |
| 7 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 8 | SELEXIPAG | 24 | 0.0009 |
| 9 | CANDESARTAN | 33 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 64 |
| 1 | Prostacycline Vasodilator [EPC] | 43 |
| 2 | Proton Pump Inhibitor [EPC] | 41 |
| 3 | Benzodiazepine [EPC] | 39 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 36 |
| 5 | Thiazide Diuretic [EPC] | 36 |
| 6 | Catecholamine [EPC] | 32 |
| 7 | Vasodilator [EPC] | 30 |
| 8 | alpha-Adrenergic Agonist [EPC] | 30 |
| 9 | beta-Adrenergic Agonist [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 8 | 0.0026 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 24 | 0.0009 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 16 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Catecholamine [EPC] | 32 | 0.0004 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 8 | Endothelin Receptor Antagonist [EPC] | 64 | 0.0003 |
| 9 | Prostacycline Vasodilator [EPC] | 43 | 0.0003 |